Safety, Tolerability & Pharmacokinetics of LEVI-04 in Healthy Volunteers and Patients With Osteoarthritis Knee Pain
Status:
Completed
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
This is a first-in-human, phase 1, single centre, placebo-controlled, double-blind, single
ascending dose study of LEVI-04 in heathy volunteers and osteoarthritis patients (with pain
attributed to osteoarthritis of the knee)
Phase:
Phase 1
Details
Lead Sponsor:
Levicept
Collaborators:
Hammersmith Medicines Research MAC Clinical Research